NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company’s fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also provides IVF treatment; surrogacy and ancillary caring services, including regular body check, as well as vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company offers its services through its clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.
Metrics to compare | NIVF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNIVFPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.4x | −7.7x | −0.5x | |
PEG Ratio | 0.01 | 0.05 | 0.00 | |
Price / Book | −1.2x | 0.4x | 2.6x | |
Price / LTM Sales | 0.2x | 0.1x | 3.1x | |
Upside (Analyst Target) | - | 19.8% | 51.1% | |
Fair Value Upside | Unlock | 38.3% | 8.9% | Unlock |